Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Hideki Nishimura

1PUBLICATIONS

18CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 26, 2025

Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (JCOG0905): A Multicenter, Open-Label, Randomized Trial.

Hiroaki Hiraga, Ryunosuke Machida, Akira Kawai

Pageof 1

Frequent Collaborators

1 joint publications

Hiroaki Hiraga

1 joint publications

Toshiyuki Kunisada

1 joint publications

Makoto Endo

1 joint publications

Akihito Nagano

1 joint publications

Shinichirou Yoshida

1 joint publications

Kunihiro Asanuma

1 joint publications

Taisuke Furuta

1 joint publications

Robert Nakayama

1 joint publications

Toshihiro Akisue

1 joint publications

Koji Hiraoka

Frequent Collaborators

1 joint publications

Hiroaki Hiraga

1 joint publications

Toshiyuki Kunisada

1 joint publications

Makoto Endo

1 joint publications

Akihito Nagano

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

See more related videos